"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Ciclosporin (Primary) ; Rituximab (Primary)
- Indications Membranous glomerulonephritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms MENTOR
- 21 Feb 2018 Planned End Date changed from 1 Oct 2017 to 1 Oct 2019.
- 21 Mar 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.
- 20 May 2016 New trial record